World's Best Scientists 2026 revealed!
Biological and Pharmaceutical Bulletin
H-index 18

Biological and Pharmaceutical Bulletin

0918-6158

Published by: The Pharmaceutical Society of Japan

https://www.jstage.jst.go.jp/browse/bpb/list/-char/en

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Chemistry 681 52 62 10
Medicine 2804 36 47 7

Additional Metrics

Number of Best Scientists*: 259
Documents by Best Scientists*: 333
Top 100 Ranked Scientists*: 5
SCIMAGO H-index: 139
SCIMAGO SJR: 0.541
Impact Factor: 1.7

Overview

Top Research Topics at Biological & Pharmaceutical Bulletin?

Biological & Pharmaceutical Bulletin covers a variety of subjects, including Biochemistry, Pharmacology, Internal medicine, Endocrinology and Molecular biology. The in-depth study on Biochemistry also explores topics in the intersecting field of Stereochemistry. While Pharmacology is the focus of the journal, it also provided insights into the studies of Anesthesia, Immunology and In vivo.

Specifically, studies on Receptor are prevalent in the Internal medicine works discussed. Topics in Molecular biology explored in the journal were investigated in conjunction with research in Cell culture and Apoptosis. The work tackled in the journal goes beyond the discipline of Pharmacokinetics as it also encompasses Chromatography.

  • Biochemistry (25.97%)
  • Pharmacology (22.31%)
  • Internal medicine (21.75%)

What are the most cited papers published in the journal?

  • Practical Aspects of the Ligand-Binding and Enzymatic Properties of Human Serum Albumin (691 citations)
  • A combined assay of cell viability and in vitro cytotoxicity with a highly water-soluble tetrazolium salt, neutral red and crystal violet. (638 citations)
  • let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. (567 citations)

Research areas of the most cited articles at Biological & Pharmaceutical Bulletin:

The most cited articles are organized to reinforce research efforts on Biochemistry, Pharmacology, Internal medicine, Endocrinology and Traditional medicine. The published papers with studies in Biochemistry featured incorporate elements of Molecular biology and Cell culture. The journal papers hold forums on Pharmacology that merge themes from other disciplines such as Immunology and In vivo.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Enzyme
  • Gene

The previous edition focused in particular on these issues:

The journal generally zeroes in on subjects such as Internal medicine, Pharmacology, Cell biology, Endocrinology and Cancer research. The studies tackled, which mainly focus on Internal medicine, apply to Gastroenterology as well. Biological & Pharmaceutical Bulletin tackles studies in Inflammation and the interrelated subject of Lipopolysaccharide to gain insights into Pharmacology.

The work on Cell biology tackled in Biological & Pharmaceutical Bulletin brings together disciplines like Tumor necrosis factor alpha and Immune system. Biological & Pharmaceutical Bulletin explores issues in Cancer research which can be linked to other research areas like Cancer cell, Apoptosis, Programmed cell death and Kinase. The studies on Apoptosis discussed can also contribute to research in the domains of Cell, Reactive oxygen species, Downregulation and upregulation and Molecular biology.

The most cited articles from the last journal are:

  • The Differential Selectivity of Aryl Hydrocarbon Receptor (AHR) Agonists towards AHR-Dependent Suppression of Mammosphere Formation and Gene Transcription in Human Breast Cancer Cells (3 citations)
  • Nicotine Enhances Firing Activity of Layer 5 Pyramidal Neurons in the Medial Prefrontal Cortex through Inhibition of Kv7 Channels. (2 citations)
  • Angiotensin (1-7) Attenuates the Nociceptive Behavior Induced by Substance P and NMDA via Spinal MAS1. (2 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Biological & Pharmaceutical Bulletin (based on the number of publications) are:

  • Dong-Hyun Kim (60 papers) absent at the last edition,
  • Naoto Oku (48 papers) absent at the last edition,
  • Hideyoshi Harashima (47 papers) absent at the last edition,
  • Naohito Ohno (45 papers) absent at the last edition,
  • Kyung-Tae Lee (42 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Biological & Pharmaceutical Bulletin (based on the number of publications) are:

  • University of Tokyo (367 papers) published 3 papers at the last edition the same number as at the previous edition,
  • University of Shizuoka (302 papers) published 5 papers at the last edition, 2 less than at the previous edition,
  • Kyoto University (257 papers) published 6 papers at the last edition, 4 less than at the previous edition,
  • Kyung Hee University (249 papers) absent at the last edition,
  • Nagoya City University (230 papers) published 2 papers at the last edition, 2 less than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 7.11% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 19.14% were posted by at least one author from the top 10 institutions publishing in the journal. Another 16.27% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 26.79% of all publications and 37.80% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Top Publications

  • Claudin-5: A Pharmacological Target to Modify the Permeability of the Blood–Brain Barrier

    (2021)
    31 Citations
  • Astragaloside IV Ameliorates Cognitive Impairment and Neuroinflammation in an Oligomeric Aβ Induced Alzheimer’s Disease Mouse Model &lt;i&gt;via&lt;/i&gt; Inhibition of Microglial Activation and NADPH Oxidase Expression

    (2021)
    26 Citations
  • Passiflora edulis Leaf Extract: Evidence of Antidiabetic and Antiplatelet Effects in Rats

    Bruno Cesar Correa Salles;Marcelo Aparecido da Silva;Lara Taniguthi;Juliane Naiara Ferreira

    (2020)
    17 Citations
  • Machine Learning Prediction of the Three Main Input Parameters of a Simplified Physiologically Based Pharmacokinetic Model Subsequently Used to Generate Time-Dependent Plasma Concentration Data in Humans after Oral Doses of 212 Disparate Chemicals

    Yusuke Kamiya;Kentaro Handa;Tomonori Miura;Junya Ohori

    (2021)
    17 Citations
  • Berberine Encapsulated in Exosomes Derived from Platelet-Rich Plasma Promotes Chondrogenic Differentiation of the Bone Marrow Mesenchymal Stem Cells &lt;i&gt;via&lt;/i&gt; the Wnt/β-Catenin Pathway

    (2022)
    13 Citations
  • Resolvin E1 Attenuates Chronic Pain-Induced Depression-Like Behavior in Mice: Possible Involvement of Chemerin Receptor ChemR23.

    Hiroe Suzuki;Takahisa Otsuka;Natsuko Hitora-Imamura;Kohei Ishimura

    (2021)
    13 Citations
  • Germacrone Reduces Cisplatin-Induced Toxicity of Renal Proximal Tubular Cells via Inhibition of Organic Cation Transporter.

    Sirima Soodvilai;Paranee Meetam;Lawan Siangjong;Ratchanaporn Chokchaisiri

    (2020)
    13 Citations
  • Identification and Validation of Combination Plasma Biomarker of Afamin, Fibronectin and Sex Hormone-Binding Globulin to Predict Pre-eclampsia.

    Yasuo Uchida;Tomoya Higuchi;Matsuyuki Shirota;Satoshi Kagami

    (2021)
    12 Citations
  • Docetaxel Upregulates HMGB1 Levels in Non-small Cell Lung Cancer

    Miya Haruna;Michinari Hirata;Kota Iwahori;Takayuki Kanazawa

    (2020)
    12 Citations
  • A Novel Binary Supercooled Liquid Formulation for Transdermal Drug Delivery.

    Yuya Hirakawa;Hiroshi Ueda;Rie Wakabayashi;Noriho Kamiya

    (2020)
    11 Citations

Related Online Degrees & Career Pathways

For students interested in Medicine, exploring related fields can open diverse career options. Many degree holders in life sciences pursue roles highlighted in biology major careers, which often provide strong foundations for medical and healthcare professions.

Another growing area in healthcare is medical coding and billing. Understanding the distinctions between certifications, such as the CPC vs. CCS, is crucial for entering this field. More details on these credentials, including cost and salary prospects, can be found by exploring ccs certification.

Medical coding offers a competitive salary and flexible work environments. Those looking to specialize can learn how to start by visiting resources on medical coder salary and career paths.

However, it’s important to consider the job outlook and challenges in this sector. For a balanced view, check out the medical coding job outlook, which outlines both opportunities and potential pitfalls in the profession.

Best Scientists Contributing to This Journal

Recently Published Articles